Neuropace Inc Cash Flow-to-Debt Ratio
Neuropace Inc cash flow-to-debt ratio. Neuropace Inc (NPCE) has a Cash Flow-to-Debt Ratio of -0.05x as of June 2026, meaning its operating cash flow of $-3.90 Million could theoretically repay 0% of its total liabilities ($85.11 Million) in one year. See how financially flexible is Neuropace Inc to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Neuropace Inc (2019–2025)
Cash flow-to-debt ratio of Neuropace Inc from 2019 to 2025. Historical debt coverage capacity for Neuropace Inc across 7 annual periods. Check NPCE cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Neuropace Inc Cash Flow-to-Debt Ratio by Year (2019–2025)
Neuropace Inc cash flow-to-debt ratio by year from 2019 to 2025. Year-by-year debt coverage analysis for Neuropace Inc. For the full cash flow conversion analysis, see NPCE cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.13x | $-11.01 Million | $86.53 Million | ▲ +38.6% |
| 2024 | -0.21x | $-17.95 Million | $86.63 Million | ▲ +8.5% |
| 2023 | -0.23x | $-19.70 Million | $87.00 Million | ▲ +51.3% |
| 2022 | -0.46x | $-36.87 Million | $79.33 Million | ▼ -13.6% |
| 2021 | -0.41x | $-24.58 Million | $60.06 Million | ▼ -285.9% |
| 2020 | -0.11x | $-21.61 Million | $203.78 Million | ▲ +36.3% |
| 2019 | -0.17x | $-25.03 Million | $150.44 Million | — |